Related Experiment Video
Updated: Jun 27, 2026
09:37
Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Failing heart; remodel, replace or repair?
Ahmet Rüçhan Akar1, Serkan Durdu, Günseli Cubukçuoğlu Deniz
1Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine and Ankara University Biotechnology Institute, Ankara, Turkey. rakar@medicine.ankara.edu.tr
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|December 11, 2008
Summary
Stem cells show promise for regenerative medicine, but challenges like cell survival and differentiation in cardiac repair need more research. Understanding these processes is key to advancing cardiovascular medicine.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Stem cells are crucial for regenerative medicine due to their self-renewal and differentiation capabilities.
- Cardiac regeneration strategies using stem cells face complex molecular challenges, including poor cell survival post-transplantation.
- Current treatments for end-stage heart failure primarily rely on cardiac transplantation.
Purpose of the Study:
- To explore the potential of stem cells in cardiac regeneration.
- To highlight the critical research areas needed for successful stem cell-based cardiac repair.
- To discuss the current limitations and future prospects of cardiac cytotherapy.
Main Methods:
- Review of stem cell behavior (self-renewal, clonogenicity, differentiation).
- Analysis of molecular mechanisms in stem-cell-driven cardiac regeneration.
- Examination of challenges in stem cell homing, migration, retention, engraftment, survival, and differentiation.
Main Results:
- Stem cell-driven cardiac regeneration involves complex molecular processes.
- Significant issues persist regarding transplanted cell survival and engraftment in the heart.
- Regeneration of contractile tissue in human studies shows modest benefits and requires careful interpretation.
Conclusions:
- Further research into stem cell fate and function is essential for cardiac cytotherapy.
- Overcoming cell death and improving engraftment are critical for successful stem cell therapy in the heart.
- A rigorous, evidence-based approach is necessary to realize the full potential of stem cells in cardiovascular medicine.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.